Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis

Department of Psychology, University of Pennsylvania, 3720 Walnut St, Philadelphia, PA 19104, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 35.29). 01/2010; 303(1):47-53. DOI: 10.1001/jama.2009.1943
Source: PubMed


Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression.
To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression.
PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews.
Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included.
Individual patient-level data were obtained from study authors.
Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25.
The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.

Download full-text


Available from: Richard C Shelton, Jan 31, 2015
  • Source
    • "A few earlier studies have considered the use of antidepressants (Dave, Petersen, Sherr, & Nazareth, 2010;Kruk & Reinhold, 2014), but most have relied on self-reporting of symptoms. The latter approach probably leads to more 'cases', but more heterogeneity in severity as antidepressants are typically prescribed for serious and moderate depression (Fournier et al., 2010;H€ am€ al€ ainen et al., 2009). We used a very large register-based data set covering the entire Norwegian population and including 1.3 million observations (whereas earlier studies have typically included 1000À25,000). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Life course influences on later life depression may include parenting trajectories. We investigate associations between number and timing of births and use of antidepressant medication in late mid-life using data on the whole Norwegian population. Methods: We estimated logistic regression models to analyse variations in the purchase of antidepressants between 2004 and 2008 by timing of births and number of children among women and men aged 45-73, using Norwegian population register data. We controlled for age, education, marital and partnership status, and (in some models) family background shared among siblings. Results: Mothers and fathers of two or more children were generally less likely to purchase antidepressants than the childless. Mothers who started childbearing before age 22 were an exception, although according to sibling models they were not more likely to purchase antidepressants. All models showed that women who became mothers before age 26 and had only one child had higher odds of medication purchase than the childless. Older age at first birth was generally associated with lower risks of antidepressant purchase. Conclusion: This analysis of high-quality data for a national population indicates that early motherhood, childlessness and low parity are associated with higher usage of antidepressants in late mid-life. Our data did not allow identification of mediating pathways, and we lacked information on early mental and physical health and some other potentially important confounders not shared between siblings. Furthermore purchase of antidepressants is not a perfect indicator of depression. Those concerns aside, the results suggest complex effects of fertility on depression that merit further investigation.
    Preview · Article · Dec 2015 · Aging and Mental Health
  • Source
    • "Interviewers were expert in the HRSD and reliability was maintained above 0.90. HRSD scores >14 are considered to indicate moderate to severe depression; scores <8 indicate return to normal [15]. These cut-off scores were used to define depression and remission status. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Current methods for depression assessment depend almost entirely on clinical interview or self-report ratings. Such measures lack systematic and efficient ways of incorporating behavioral observations that are strong indicators of psychological disorder. We compared a clinical interview of depression severity with automatic measurement in 48 participants undergoing treatment for depression. Interviews were obtained at 7-week intervals on up to four occasions. Following standard cutoffs , participants at each session were classified as remitted, intermediate, or depressed. Logistic regression classifiers using leave-one-out validation were compared for facial movement dynamics, head movement dynamics, and vocal prosody individually and in combination. Accuracy (remitted versus depressed) for facial movement dynamics was higher than that for head movement dynamics; and each was substantially higher than that for vocal prosody. Accuracy for all three modalities together reached 88.93%, exceeding that for any single modality or pair of modalities. These findings suggest that automatic detection of depression from behavioral indicators is feasible and that multimodal measures afford most powerful detection.
    Full-text · Conference Paper · Nov 2015
  • Source
    • "Due to the lack of outpatient psychotherapists, patients with mild to moderate symptoms of depression often receive antidepressant medication (Holzinger et al., 2011). This is in contrast to recommendations of treatment guidelines (Fournier et al., 2010), and contrary to treatment preferences of those afflicted, who mostly prefer psychotherapy (Houle et al., 2013). Furthermore, persons with depression are often reluctant to seek professional help (Cuijpers, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Only a minority of people suffering from depression receive adequate treatment. Psychological Online Interventions (POIs) could help bridge existing treatment gaps and augment the effectiveness of current treatments. Apart from effectiveness, user acceptance of POIs must be achieved if such interventions are to be broadly implemented in existing health-care. Valid measurement tools examining attitudes towards POIs are lacking. Therefore, we examined the dimensionality of attitudes towards POIs, developed a novel questionnaire, the Attitudes towards Psychological Online Interventions Questionnaire (APOI), and gathered data to examine its reliability. We recruited a sample of 1004 adults with mild to moderate depressive symptoms from a range of sources. We constructed a set of 35 items based on literature review as well as expert and patient queries. The initial items were subjected to an exploratory factor analysis (EFA) in a randomly selected subsample. A final set of 16 items was subjected to a confirmatory factor analysis (CFA) to cross-validate the factor structure in a separate subsample. The EFA revealed four dimensions: "Scepticism and Perception of Risks", "Confidence in Effectiveness", "Technologization Threat" and "Anonymity Benefits". The model fit in the CFA was excellent relating to all applied indices (χ(2)=105.816, p=.651; SRMR=.042; RMSEA=.013; CFI=.994) and the APOI total scale showed acceptable to good internal consistency. Further research with the APOI might facilitate the development and dissemination of POIs and, ultimately, help improve the quality of care for people experiencing depressive symptoms. Copyright © 2015 Elsevier B.V. All rights reserved.
    Full-text · Article · Sep 2015 · Journal of Affective Disorders
Show more